STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients

Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer

(2019) Ulrich Krafft et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation

(2018) Tianhong Su et al.   ONCOGENE

Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways

(2018) Mathieu Rouanne et al.   WORLD JOURNAL OF UROLOGY

Prognostic significance of STIP1 expression in human cancer: A meta-analysis

(2018) Shupeng Zhang et al.   CLINICA CHIMICA ACTA

An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer

(2017) Roland Seiler et al.   EUROPEAN UROLOGY

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study

(2015) Tammer Hemdan et al.   JOURNAL OF UROLOGY

Molecular markers for urothelial bladder cancer prognosis: Toward implementation in clinical practice

(2014) Bas W.G. van Rhijn et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05)

(2013) Susanne Krege et al.   BJU INTERNATIONAL

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

(2013) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials

(2013) Jeffrey J. Leow et al.   EUROPEAN UROLOGY

Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy

(2012) Muhammet Fuat Ozcan et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Cancer Drug-Resistance and a Look at Specific Proteins: Rho GDP-Dissociation Inhibitor 2, Y-Box Binding Protein 1, and HSP70/90 Organizing Protein in Proteomics Clinical Application

(2010) Helena Skalnikova et al.   JOURNAL OF PROTEOME RESEARCH

Stress-induced Phosphoprotein 1 as a Secreted Biomarker for Human Ovarian Cancer Promotes Cancer Cell Proliferation

(2010) Tzu-Hao Wang et al.   MOLECULAR & CELLULAR PROTEOMICS

Prion protein interaction with stress-inducible protein 1 enhances neuronal protein synthesis via mTOR

(2010) M. Roffe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA